References
- Youssef I, Yoon J, Mohamed N, Zakeri K, Press RH, Chen L, et al. Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy. JAMA Netw Open 2022;5:e2241538.
- Nuyts S, Bollen H, Ng SP, Corry J, Eisbruch A, Mendenhall WM, et al. Proton therapy for squamous cell carcinoma of the head and neck: Early clinical experience and current challenges. Cancers (Basel) 2022;14:2587.
- Manzar GS, Lester SC, Routman DM, Harmsen WS, Petersen MM, Sloan JA, et al. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol 2020;147:64-74.
- Mojdami ZD, Barbour A, Oveisi M, Sun C, Fine N, Saha S, et al. The effect of intensity-modulated radiotherapy to the head and neck region on the oral innate immune response and oral microbiome: A prospective cohort study of head and neck tumour patients. Int J Mol Sci 2022;23:9594.
- Zagury-Orly I, Khaouam N, Noujaim J, Desrosiers MY, Maniakas A. The effect of radiation and chemoradiation therapy on the head and neck mucosal microbiome: A review. Front Oncol 2021;11:784457.
- Villa A, Vollemans M, De Moraes A, Sonis S. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers. Support care Cancer 2021;29:6061-8.
- Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag 2015;11:45-51.
- Segata N, Haake SK, Mannon P, Lemon KP, Waldron L, Gevers D, et al. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012;13:R42.
- Chesdachai S, Tai DB, Yetmar ZA, Misra A, Ough N, Abu Saleh O. The characteristics of capnocytophaga infection: 10 years of experience. Open Forum Infect Dis 2021;8:ofab175.
- Peterson SN, Snesrud E, Schork NJ, Bretz WA. Dental caries pathogenicity: A genomic and metagenomic perspective. Int Dent J 2011;61 Suppl 1:11-22.
- Ehlers B, Spiess K, Leendertz F, Peeters M, Boesch C, Gatherer D, et al. Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus. J Gen Virol 2010;91:630-42.
- Gerner CS, Dolan A, McGeoch DJ. Phylogenetic relationships in the Lymphocryptovirus genus of the Gammaherpesvirinae. Virus Res 2004;99:187-92.
- Bilgrami S, Bergstrom SK, Peterson DE, Hill DR, Dainiak N, Quinn JJ, et al. Capnocytophaga bacteremia in a patient with Hodgkin’s disease following bone marrow transplantation: Case report and review. Clin Infect Dis 1992;14:1045-9.
- Hu YJ, Shao ZY, Wang Q, Jiang YT, Ma R, Tang ZS, et al. Exploring the dynamic core microbiome of plaque microbiota during head-and-neck radiotherapy using pyrosequencing. PLoS One 2013;8:e56343.
- Isabel R. Capnocytophaga sputigena bacteremia in a neutropenic host. IDCases 2019;17:e00536.
- Samant S, Lee H, Ghassemi M, Chen J, Cook JL, Mankin AS, et al. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 2008;4:e37.
- Goncheva MI, Chin D, Heinrichs DE. Nucleotide biosynthesis: The base of bacterial pathogenesis. Trends Microbiol 2022;30:793-804.
- Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, et al. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 2016;95:360-7.
- Baumann BC, Mitra N, Harton JG, Xiao Y, Wojcieszynski AP, Gabriel PE, et al. Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer. JAMA Oncol 2020;6:237-46.
- Gordon KB, Smyk DI, Gulidov IA. Proton therapy in head and neck cancer treatment: State of the problem and development prospects (Review). Sovrem Tekhnologii Med 2021;13:70-80.
- Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: A review of the clinical experience to date. Int J Radiat Oncol Biol Phys 2014;89:292-302.
- Lukens JN, Lin A, Hahn SM. Proton therapy for head and neck cancer. Curr Opin Oncol 2015;27:165-71.
- McKeever MR, Sio TT, Gunn GB, Holliday EB, Blanchard P, Kies MS, et al. Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer. Chin Clin Oncol 2016;5:54.
- Moignier A, Gelover E, Wang D, Smith B, Flynn R, Kirk M, et al. Improving head and neck cancer treatments using dynamic collimation in spot scanning proton therapy. Int J Part Ther 2016;2:544-54.
- Sharma S, Zhou O, Thompson R, Gabriel P, Chalian A, Rassekh C, et al. Quality of life of postoperative photon versus proton radiation therapy for oropharynx cancer. Int J Part Ther 2018;5:11-7.
- Hou J, Zheng H, Li P, Liu H, Zhou H, Yang X. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy. Radiother Oncol 2018;129:44-51.
- Freiberg JA, Le Breton Y, Tran BQ, Scott AJ, Harro JM, Ernst RK, et al. Global analysis and comparison of the transcriptomes and proteomes of group a Streptococcus biofilms. mSystems 2016;1:e00149-16.
- Duran-Pinedo AE, Chen T, Teles R, Starr JR, Wang X, Krishnan K, et al. Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis. ISME J 2014;8:1659-72.